in Health care
Lupin gets USFDA nod for primary biliary cholangitis drug Obeticholic Acid
Mumbai: Global pharma major, Lupin Limited, has announced that the company has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA), Obeticholic Acid Tablets, 5 mg and 10 mg. Obeticholic acid tablets are used for treating primary biliary cholangitis. Primary biliary cholangitis is an autoimmune disease […] More
